The Second Department of Internal Medicine and *the Central Laboratory for Clinical Investigation, Osaka University Medical School, Fukushima-ku, Osaka 553 Synopsis Ten healthy male volunteers were studied to compare the effectiveness of intravenous and subcutaneous injections of 1mg of glucagon on HGH secretion. Plasma HGH level rose to a peak of 6ng/ml or greater 120 minutes after the subcutaneous injection of glucagon (sc glucagon) in all subjects, whereas the Glucagon has been shown to stimulate various polypeptide hormones including human growth hormone (HGH) and to be applicable for estimation of HGH-secretory capacity. We have, however, as yet very little information as to the serum immunoreactive glucagon (IRG) levels achieved by intravenous and subcutaneous injection of glucagon and the mechanism of glucagoninduced HGH secretion.
The present study was performed to compare the suitability of different types of glucagon injection for clinical use in a routine test of HGH secretion and to investigate whether the stimulatory effect of glucagon on HGH secretion is related to plasma IRG level per se, or to changes in other substances in plasma.
Materials and Methods
Ten healthy, non-obese male volunteers between the ages 19 and 24 were studied. After an overnight fast the subjects were kept recumbent.
Tests were started after 30-minute bed rest. A 19-gauge needle was inserted into an antecubital vein and was kept patent by a slow saline-infusion.
After two control samples were obtained, 1mg of glucagon* was inReceived for publication July 7, 1975. * Crystalline glucagon (Novo) was kindly provided from Kodama Pharmaceuticals. 
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Japon. June 1976 jected either intravenously over a period of two minutes or subcutaneously as a bolus. Venous blood samples were collected 2, 5, 10, 15, 30, 45, 60, 90, 120, 180, and 240 minutes after iv glucagon and 15, 30, 45, 60, 90, 120, 180 , and 240 minutes after sc glucagon. When administered intravenously the midpoint of the injection was regarded as zero time for sampling thereafter.
Each volunteer was subjected to both iv and sc glucagon tests in random order with one-week intervals.
Blood glucose was determined by an Auto-Analyser with modification by the Hoffman ferricyanide technique (Hoffman, 1937) . Plasma insulin (IRI) was measured by a solid-phase antibody technique using materials purchased from Pharmacia, Sweden (Wide and Porath, 1966) . HGH was assayed by the doubleantibody radioimmunoassay (Schalch and Parker, 1964) using Wilhelmi HGH as the standard, the lower limit of sensitivity was 1ng/ml. Glucagon (IRG) was measured by the radioimmunoassay method described previously (Shima et al., 1975 ) using nonspecific antiglucagon serum. Plasma FFA was measured spectrometrically (Duncombe, 1964) and plasma lactate was determined by the method reported by Scholz et al. (1959) . Calcium and potassium were determined by flame photometry and inorganic phosphate was determined by the method of Taussky and Schorr (1953) . 
Results
Plasma HGH responses to glucagon Fig. 1 illustrates individual HGH responses to two types of glucagon injection. In iv glucagon, four of the ten subjects showed no significant responses, two had peaks of HGH responses at 30 and 45 minutes and the other four subjects had peaks after 120 minutes; a significant rise in plasma HGH was defined as a rise of Changes in plasma electrolytes after glucagon As shown in Fig. 3 , plasma potassium and inorganic phosphate were decreased significantly, but calcium did not show any significant change following the injection of glucagon.
Discussion
Mitchell and co-workers (1969) reported increased HGH levels after intramuscular or subcutaneous injection of glucagon. Since then, Cain et al. (1970 Cain et al. ( , 1972 , AvRuskin et al. (1971) and Spathis et al. (1974) have confirmed their results. However, Eddy et al. (1970) and Podolsky and Sivaprasad HGH release after glucagon injection. As shown in Fig. 1 , in sc glucagon all subjects showed a rise of more than 6ng/ml in plasma HGH after 120 minutes, whereas in iv glucagon six of ten subjects showed a smaller but significant rise in plasma HGH. These responses appeared at various intervals after the injection; the other four subjects showed no responses. Our results agree with those of Cain et al.(1970 Cain et al.( , 1972 that either intramuscular or sc injection of glucagon is a potent stimulus for HGH release but 1 mg bolus iv glucagon is not a consistent stimulus for HGH release.
There are various methods as provocative tests for HGH secretion, including the use of insulin (Roth et al., 1963) , arginine (Merimee et al., 1965) , glucagon (Mitchell et al., 1969) , levodopa (Boyd et al., 1970) , ACTH (Zahnd et al., 1969) and metyrapone (Kunita et al., 1970 The mechanism of glucagon stimulated HGH secretion is still unclear. In order to investigate whether the stimulatory effect of glucagon on HGH release may be associated with plasma IRG level itself, plasma IRG levels were measured during glucagon injection in the present experiment.
Glucagon administered intravenously disappeared rapidly from circulation, while it was retained for a longer period when administered subcutaneously as shown in This assumption is also supported by the results of Cain et al.(1970) , who showed that intravenous infusion of 1 mg glucagon for 30 minutes caused HGH responses comparable to those of 1 mg intramuscular glucagon.
There are conflicting reports in relation to whether the fall of blood glucose from its peak may stimulate HGH secretion after glucagon. Mitchell et al.(1970) suggested that falling blood glucose is not the sole mechanism responsible for HGH release by glucagon. Cain et al. (1970 and pointed out that the rate of fall of blood sugar was similar in iv glucagon but that the HGH response was less consistent in iv glucagon. Podolsky and Sivaprasad (1972) showed that sc glucagon administration did not cause any significant rise in HGH after prolonged fasting.
Blood glucose response Endocrinol. Japon. June 1976 to iv glucagon had a peak at 15 minutes and then decreased to a nadir at 120 minutes. On the contrary, following the sc injection of glucagon blood glucose rose to a peak at 30 minutes and fell to a nadir at 120 minutes. The mean fall of blood glucose was significantly (p<0.05) greater in sc Plasma lactate levels increased significantly after glucagon injection, but no significant difference was observed between iv and sc glucagon. Plasma potassium and inorganic phosphate levels decreased significantly after glucagon injection but no significant changes were observed in the plasma levels of calcium although the infusion of exogenous glucagon has been shown in most reports (Birge and Avioli, 1969) to lower the serum calcium. This discrepancy is not clear.
